Table 2.

Association between HOXA11-AS and clinicopathological characteristics of cancers

Clinicopathological parameters	Studies (n)	Patients (n)	OR (95% CI)	p value	Heterogeneity
					I2 (%)	p	Model
Age (≥ 55 vs. < 55 years)	4	259	0.66 (0.40–1.08)	0.101	0	0.899	Fixed
Gender (male vs. female)	4	259	1.05 (0.64–1.72)	0.845	0	0.483	Fixed
Lymph node metastasis (yes vs. no)	4	384	2.06 (1.31–3.25)	0.002	47.1	0.129	Fixed
Tumor stage (III–IV vs. I–II)	6	480	4.22 (2.60–6.85)	< 0.001	0	0.993	Fixed
Tumor differentiation (poor vs. well)	3	292	2.49 (1.47–4.20)	0.001	0	0.648	Fixed